Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
07/1996
07/02/1996US5532372 With a 1,2-benzisothiazole ring attached at its 3-position to a piperazine nitrogen; antipsychotics; includes lurasidone in claim 17
07/02/1996US5532262 Methylcyclohexanecarboxamide, n-dichlorohydroxyphenyl and dichlofluanid and carbendiazim
07/02/1996US5532252 For the treatment of tissue damage associated with physical trauma
07/02/1996US5532243 Antipsychotic nitrogen-containing bicyclic compounds
07/02/1996US5532237 Intraocular for treatment of glaucoma
06/1996
06/26/1996EP0718281A1 Cyclohexanediurea derivative and process for producing the same
06/26/1996EP0718280A2 Derivatives of beta-aminopropionic acid with a fungicidal activity
06/26/1996EP0717736A1 Polar-substituted hydrocarbons
06/26/1996EP0717732A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
06/26/1996EP0717622A1 Methods of treating hiv with azaspiranes
06/25/1996US5530157 Anti-inflammatory benzoic acid derivatives
06/25/1996US5530156 Intermediates for fungicides
06/25/1996US5530125 Reacting arylacetamide with strong base in inert aprotic solvent, then with specified reactant in presence of transition metal catalyst to add alpha-substituent,reducing to amine
06/25/1996US5530089 Oligomers having crosslinking end cap moieties which provide solvent resistant composites; prepregs
06/25/1996US5530022 Insecticides
06/25/1996US5530019 For treatment of prostate gland disorders
06/20/1996WO1996018608A1 Aniline derivatives having nitrogen monoxide synthase inhibitory activity
06/20/1996WO1996018607A1 Aniline derivative having the effect of inhibiting nitrogen monoxide synthase
06/20/1996WO1996018592A1 Resin-bound phosphonium salts and their use in organic synthesis
06/20/1996WO1996018393A1 Novel compounds
06/20/1996WO1996004241A3 Benzoylguanidine derivatives as medicaments
06/19/1996EP0716650A1 Indole and indoline derivatives as 5ht1d receptor antagonists
06/18/1996USRE35279 Aldose reductase inhibitors
06/18/1996US5527910 Bactericides; staphylococcus, streptococcus infections
06/18/1996US5527820 Antibiotics having immunosuppressive activity, delaminomycins and processes for the production of the same
06/18/1996US5527819 Treating aids
06/18/1996US5527812 Cyclic nitrones
06/18/1996US5527800 Tricyclic condensed heterocyclic compounds, their production and use
06/18/1996US5527523 Hydroquinone amino-acid esters, methods of preparation, and pharmaceutical or cosmetic compositions containing them
06/13/1996WO1996017828A1 Resolution and reduction of physostigmine intermediates and derivatives
06/13/1996WO1996017628A1 In-vivo diagnostic process by near infrared radiation
06/13/1996DE4445065A1 Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung A method for in vivo diagnosis using NIR radiation
06/13/1996DE4443890A1 Use of new or known substd. amino-cyclohexene carboxylic acid derivs.
06/12/1996EP0716077A1 Aromatically substituted omega amino alcanoic acid amides and alcanoic diamides and their use as renine inhibitors
06/12/1996EP0715627A1 Indole derivatives as thromboxane a2 antagonists
06/12/1996EP0422134B1 5-ht selective agents
06/12/1996CN1124486A Heterocycle-containing amidine derivatives, their preparation and use
06/12/1996CN1124484A 3-(indol-3-YL) propenoic acid derivatives and as NMDA antagonists
06/12/1996CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles
06/11/1996US5525727 Brain-specific drug delivery
06/11/1996US5525615 Cardiovascular disorders
06/09/1996CA2164571A1 Aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides
06/06/1996WO1996017020A1 Multifunctional cyanate ester and epoxy blends
06/06/1996WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p
06/06/1996WO1996016938A1 Indole derivative
06/06/1996CA2206307A1 Indole derivative
06/05/1996EP0714883A1 Aryloxypropanolamine beta 3 adrenergic agonists
06/05/1996EP0714418A1 Cosmetic melanins
06/05/1996EP0714302A1 Therapeutic compounds
06/04/1996US5523412 Intermediates for 4-arylcyclohepta[c]pyrrole analgesics
06/04/1996US5523313 Hypotensive agents; cardiotonic agents; inhibitors of neutral metalloendopeptidases; vasodilation; heart failure and renal insufficiency
06/04/1996US5523306 Amino acid derivatives cyclized at the C-terminal
06/04/1996US5523299 Administering in treatment of psychotic disorders
06/04/1996US5523152 Organic compounds suitable as reactive diluents, and binder precursor compositions including same
06/03/1996CA2164246A1 Aryloxypropanolamine beta 3 adrenergic agonists
05/1996
05/30/1996WO1996016056A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists
05/30/1996WO1996016044A1 Iminooxymethylene anilides, process for preparing the same and their use
05/30/1996WO1996016041A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
05/30/1996WO1996016038A1 2-[2-(indol-3-yl)ethylamino]-1-phenylethanol derivative
05/30/1996WO1996016027A1 Matrix metalloprotease inhibitors
05/30/1996WO1996016015A1 Dichroic light polarizers
05/30/1996DE4441676A1 Iminooxymethylenanilide, Verfahren zu ihrer Herstellung und ihre Verwendung Iminooxymethylenanilide, processes for their preparation and their use
05/30/1996CA2206270A1 Iminooxymethyleneanilides, process for preparing the same and their use
05/30/1996CA2205665A1 Matrix metalloprotease inhibitors
05/30/1996CA2205661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists
05/29/1996EP0713702A1 Anxiolytic agent
05/29/1996EP0713701A1 2-Bromomelatonin in the therapy of sleep disorders
05/29/1996EP0713484A1 Inhibitors of biogenic amine transporters
05/29/1996CN1123546A 4-arylisoindole analgesics
05/29/1996CN1123280A Novel pyrrolocarbazoles
05/29/1996CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication
05/28/1996US5521320 Process for the enantioselective synthesis of intermediates used in the preparation of physostigmine
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521220 Treating inflammatory and central nervous system disorders
05/28/1996US5521213 Nonsteroid antiinflammatory agents
05/28/1996US5521209 N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof
05/28/1996US5521170 Benzamide derivatives and pharmaceutical composition comprising the same
05/28/1996US5521039 Electrophotographic photosensitive material and printing plate for electrophotographic process
05/28/1996US5520844 Imide-aromatic peroxyacids as bleaching agents
05/28/1996CA1338354C Process for preparing halogen imides and their use as fire retardants
05/28/1996CA1338353C Process for preparing halogen imides
05/23/1996WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996WO1996015131A1 Macrocyclic lactone compounds and their production process
05/23/1996WO1996015125A1 Nonpeptide endothelin antagonists
05/23/1996WO1996015109A1 Endothelin antagonists
05/23/1996WO1996015100A1 Heterocyclic compounds, their preparation and use
05/23/1996WO1996015099A1 Heterocyclic compounds, their preparation and use
05/23/1996WO1996015096A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
05/23/1996WO1996014857A1 Multicatalytic protease inhibitors
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996CA2203681A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996CA2202760A1 Multicatalytic protease inhibitors
05/23/1996CA2202051A1 Nonpeptide endothelin antagonists
05/22/1996EP0712845A1 Amine compounds, their production and use
05/22/1996EP0712844A1 Novel fused-ring carboxylic acid compound or salt thereof, and medicinal use thereof
05/22/1996EP0712389A1 Therapeutic compound - fatty acid conjugates
05/22/1996EP0712387A1 2-aminoindans as selective dopamine d3 ligands
05/22/1996EP0700381A4 Process for the enantioselective synthesis of intermediates used in the preparation of physostigmine
05/22/1996CA2163325A1 Amine compounds, their production and use
1 ... 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 ... 458